Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€64.20

€64.20

-0.590%
-0.38
-0.590%
€76.33
 
09:30 / Tradegate WKN: 934623 / Symbol: MET / Name: MetLife / Stock / Insurance / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction

Metlife Inc. Stock

The price for the Metlife Inc. stock decreased slightly today. Compared to yesterday there is a change of -€0.380 (-0.590%).
With 15 Buy predictions and not the single Sell prediction the community is currently very high on Metlife Inc..
As a result the target price of 76 € shows a slightly positive potential of 18.38% compared to the current price of 64.2 € for Metlife Inc..
For the coming years our community has positive and negative things to say abot the Metlife Inc. stock. Criterium "Expected dividend yield" gathered the most positive votes but regarding "Revenue growth" there were negative voices in the community.

MetLife Inc. (Symbol: MET) (WKN: 934623) is a globally renowned insurance, annuities, and employee benefits company, founded in 1868, with its headquarters in New York City. As a leading player in the financial services sector, this Fortune 500 company offers a comprehensive range of products and services, including life insurance, dental and vision coverage, accident and health insurance, retirement and savings solutions, and more. Boasting a diverse clientele, MetLife serves individual customers, SMEs, and large-scale corporations across the globe, with a strong focus on enhancing value for its shareholders, policyholders, and clients. With an underlying commitment to innovation and customer-centric strategies, this publicly traded company (NYSA: MET) has established its presence in more than 40 countries, continuing to expand its horizons in the changing dynamics of global demographics and financial security needs.

Pros and Cons of Metlife Inc. in the next few years

Pros
?
B****
?
G***** c******* t* c**********
?
M***** P*******
Cons
?
S********** s********
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Metlife Inc. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Metlife Inc. -0.590% -3.468% -2.873% 14.707% 7.777% 23.338% 59.693%
Principal Financial Group -1.350% -2.632% -2.632% 6.475% 2.778% 39.623% 50.010%
Prudential Financial -0.100% -3.432% -2.267% 27.134% 8.389% 22.728% 10.133%
Lincoln National -0.830% -8.476% 1.247% 25.361% 0.600% -53.835% -57.349%

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2023-04-15

MetLife, a prominent company in the insurance industry with the US symbol MET, seems to have a steady footing in terms of its overall financial standing. Glancing at the company's yearly and quarterly financial statements, it is evident that MetLife has a significant asset base and a stable net income. However, a deeper analysis of the company's financials is necessary to understand the pros and cons, which will help assess the company's performance and growth potential.

*Pros: *

Significant asset base: MetLife has a strong asset base, with total assets worth $666.61 billion as of December 31, 2022. This indicates that the company has a vast array of resources to support its operations and generate revenue. With a strong asset base, MetLife can leverage its resources for continued growth and better risk management.

Comments

Prediction Buy
Perf. (%) -2.12%
Target price 77.113
Change
Ends at 15.04.25

MetLife, Inc. (NYSE: MET) had its price target raised by analysts at Morgan Stanley from $80.00 to $82.00. They now have an "overweight" rating on the stock.
Ratings data for MET provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -2.86%
Target price 80.272
Change
Ends at 11.04.25

MetLife, Inc. (NYSE: MET) had its price target raised by analysts at Wells Fargo & Company from $83.00 to $86.00. They now have an "overweight" rating on the stock.
Ratings data for MET provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -3.59%
Target price 81.049
Change
Ends at 10.04.25

MetLife, Inc. (NYSE: MET) had its price target raised by analysts at Keefe, Bruyette & Woods from $82.00 to $87.00. They now have an "outperform" rating on the stock.
Ratings data for MET provided by MarketBeat
Show more